Viewing Study NCT00621218


Ignite Creation Date: 2025-12-25 @ 4:53 AM
Ignite Modification Date: 2026-03-03 @ 2:20 AM
Study NCT ID: NCT00621218
Status: COMPLETED
Last Update Posted: 2008-12-18
First Post: 2008-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Determine the Safety and Efficacy of Atralin (Tretinoin 0.05%) Gel for the Treatment of Rosacea
Sponsor: Coria Laboratories, Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 9320-010-002
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: None
Responsible Party Affiliation:
Old Name: D. Innes Cargill, PhD
Old Organization: Coria Laboratories, Ltd.

Collaborators